More Evidence Supports Early Start to Therapy in MS More Evidence Supports Early Start to Therapy in MS

11-year BENEFIT follow-up suggests that immediate vs delayed treatment at first signs of multiple sclerosis reduces risk for second event and decreases relapse rate.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news